Skip to content

Viemed Healthcare, Inc. VMD Noncontrolling interests in subsidiaries

Noncontrolling interests in subsidiaries at other companies

AdaptHealth logo
AdaptHealthAHCO
$7.41M+22.3%
The Pennant Group, Inc. logo
The Pennant Group, Inc.PNTG
$43.42M+123%
Cardinal Health logo
Cardinal HealthCAH
$160M-84.8%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
IQVIA logo
IQVIAIQV

Other financials

Income statement

See full
Revenue$75.4M+27.5%
Gross profit$42.8M+28.7%
Operating income$4.3M+11.8%
Net income$2.6M-1.6%
EPS (diluted)$0.060.0%

Balance sheet

See full
Cash & equivalents$9.8M-3.9%
Total debt$12.4M+84.0%
Total equity$143.9M+6.8%
Total assets$197.4M+10.8%

Cash flow

See full
Operating cash flow$8.1M+183%
CapEx$6.7M-56.6%
Free cash flow$1.4M+111%

Valuation

See full
Market cap$448.16M+71.3%
Enterprise value$450.83M+74.6%
P/E30.1×+8.8×
P/S1.6×+0.4×

Profitability

See full
Gross margin57.6%-1.1pp
Operating margin8.2%-0.2pp
Net margin5.2%-0.1pp
FCF margin9%

Returns & leverage

See full
Return on equity10.7%+0.9pp
Debt / equity0.1×0.0×
Current ratio1.2×-0.2×

Where this comes from

Reported directly by Viemed Healthcare, Inc. in its filing.

Tagged under the XBRL concept us-gaap:MinorityInterest.

The official record: Viemed Healthcare, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viemed Healthcare, Inc.'s noncontrolling interests in subsidiaries.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viemed Healthcare, Inc.'s noncontrolling interests in subsidiaries?
Viemed Healthcare, Inc. (VMD) reported noncontrolling interests in subsidiaries of $1.93M in Q1 2026.
How has Viemed Healthcare, Inc.'s noncontrolling interests in subsidiaries changed year-over-year?
Viemed Healthcare, Inc.'s noncontrolling interests in subsidiaries decreased by 3.0% year-over-year, from $1.99M to $1.93M.
What does noncontrolling interests in subsidiaries mean?
This represents the portion of a subsidiary's net assets that is owned by outside shareholders rather than the parent company. It is reported within equity to show the total value of the subsidiary's assets and liabilities that are not attributable to the parent. It reflects the non-controlling stake in consolidated entities.